#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

Update: 2021-05-06

Description

Matthew Scholz is the co-founder of Oisin Biotechnologies, a gene therapy platform company that is targeting aging by killing senescent cells. We discuss the technology behind Oisin, Matt's journey from computer science to biotech, and practical advice and wisdom he gained from building biotech startups.

Comments

In Channel

#020: Daniel Oliver (Rejuvenate Bio) - July 21, 2021

2021-07-2101:12:09

#019: Future of Longevity II (George Church, Nir Barzilai, Kristen Fortney, Jim Mellon, Alejandro Ocampo, Jay Olshansky) - July 14th, 2021

2021-07-1401:20:15

#018: Anil Bhushan (Deciduous Therapeutics) - July 1st, 2021

2021-07-0101:05:18

#017: Longevity Panel: The scientists working on reversing aging - June 15th, 2021

2021-06-1602:06:15

#016: Sebastian Brunemeier (ex Apollo Health Ventures, co-founder Cambrian Biopharma) - June 10th, 2021

2021-06-1001:14:45

#015: Marinna Madrid (Cellino) - June 3rd, 2021

2021-06-0301:04:42

#014: Tyler Golato (VitaDAO) - May 27th, 2021

2021-05-2701:01:13

#013: Marco Quarta (Rubedo Life Sciences) - May 20th, 2021

2021-05-2101:05:36

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

2021-05-0601:14:36

#011: Kristen Fortney (BioAge Labs) - April 29th, 2021

2021-04-2901:03:08

#010: Jean Hebert (Albert Einstein College of Medicine, "Replacing Aging") - April 22nd, 2021

2021-04-2202:08:37

#009: Keshav Singh & Greg Schmerge (Yuva Biosciences) - April 15th, 2021

2021-04-1501:22:20

#008: Marc Bernegger, Tobias Reichmuth, Collin Ewald (Maximon) - April 8th, 2021

2021-04-0801:31:18

#007: Daniel Ives (Shift Bioscience) - April 1st, 2021

2021-04-0103:00:30

00:00

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

The Longevity Biotech Show

#box-pro-ellipsis-175928267825011{-webkit-line-clamp:2;}#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021

The Longevity Biotech Show

#012: Matthew Scholz (Oisin Biotechnologies) - May 6th, 2021